Informations générales
940110018
8610Z
Centre Hospitalier (C.H.)
Etablissement Public Intercommunal d'Hospitalisation
94
Adresse
| 40 AV DE VERDUN 94010 CRETEIL CEDEX | Accès au plan |
Contact pour la recherche clinique
n/c
n/c
Chiffres clés
| Nombre de lits | 461 |
| Nombre de places | 104 |
| Nombre de passages aux urgences/an | 130000 |
| Nombre d'accouchements/an | 3700 |
La recherche
Informations générales
| Unité de recherche clinique | |
| Nombre d'equivalents temps plein personnels de recherches | 24 |
| DRCI référente de proximité | |
| Nombre d'essais dont l'établissement est promoteur | 53 |
| Nombre d'essais à finalité commerciale dont l'établissement est coordonateur | 4 |
| Nombre d'essais à finalité commerciale dont l'établissement est associé |
Thématiques de recherche
Plateaux techniques
| Hopital de jour | |
| CRB | |
| Scanner | |
| IRM | |
| Echographie | |
| PUI | |
| PUI avec préparation de chimiothérapie | |
| Hémodialyse | |
| Equipement de rééducation fonctionnelle | |
| Bloc chirurgical | |
| Bloc obstétrique | |
| TEP |
Listes des essais cliniques en recrutement
| Etude | Statut | Dernière mise à jour | |
|---|---|---|---|
| NCT05407636 | A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD (ASCENT) | 17 octobre 2024 | |
| NCT05781308 | A Non-comparative Randomized Phase II Trial Evaluating the Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients with Advanced Non-squamous NSCLC Progressing After Immunotherapy and Chemotherapy (ADAPTABLE) | 16 octobre 2024 | |
| NCT03774732 | PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer (NIRVANA-LUNG) | 20 septembre 2024 | |
| NCT04781933 | Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement (ICAN) | 07 septembre 2024 | |
| NCT04707235 | ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension | 28 août 2024 | |
| NCT04547504 | Randomized, Open-label, Controlled Phase III Trial Comparing Pembrolizumab-platinum Based Chemotherapy Combination With Pembrolizumab Monotherapy in First Line Treatment of Non-small-cell Lung Cancers (NSCLC) With PDL1 Expression ≥50% (PERSEE) | 10 août 2024 | |
| NCT04262921 | Clinical Characterisation Protocol for Severe Emerging Infections (FrenchCOVID) | 31 juillet 2024 | |
| NCT03386734 | International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer (SENTICOLIII) | 09 juillet 2024 | |
| NCT05439733 | Planned Mode of Delivery After Caesarean: a Comparative Prospective National Population-based Cohort Study (CICAMODA) | 26 juin 2024 | |
| NCT04658329 | Cohorte ANRS CO5 "Cohorte Nationale VIH2" (ANRS CO VIH2) | 15 juin 2024 | |
| NCT04067596 | Very Large Sizes in Adolescents: Interest of the Tibial and Femoral EPIphysiodesis in Case of Request for Treatment. (GREPI) | 15 juin 2024 | |
| NCT04016246 | Respiratory Effect of the LISA (Less Invasive Surfactant Administration) Method With Sedation by Propofol Versus Absence of Sedation: Double-blind Comparative Randomized Clinical Trial. (PROLISA) | 15 juin 2024 | |
| NCT03622983 | Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization (PELVIMASS2) | 15 juin 2024 | |
| NCT03626233 | Study of the Physiology of Pre-eclampsia and Vascular Intrauterine Growth Restriction With Constitution of a Biological Collection (CPVP) | 15 juin 2024 | |
| NCT03916939 | Contribution of Osteopathic Treatment to Alcohol Withdrawal Syndrome in Hospitalized Adult Patients (OSTEOOL) | 15 juin 2024 | |
| NCT04499820 | Effet d'Une supplémentation Par OMEGA3 Dans la rétinopathie diabétique (OMEDIA) | 15 juin 2024 | |
| NCT04823377 | Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. (PACT-01) | 15 juin 2024 | |
| NCT02433132 | Study of Ion Transport From Nasal Epithelial Cells Collected by Brushing (CCBN) in the Diagnosis of Atypical Forms of Cystic Fibrosis (MUCO-BROCC) | 15 juin 2024 | |
| NCT04881253 | COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA) | 15 juin 2024 | |
| NCT05053932 | Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Children With Sickle Cell Anemia ( DREPAGREFFE-2) (DREPAGREFFE2) | 15 juin 2024 | |
| NCT04621188 | A Phase II Single-group Assignment, Multicenter Study of Efficacy and Safety of Lorlatinib Monotherapy After Failure of First-line Tyrosine Kinase Inhibitor in Patients with Advanced ROS1-positive Non-small Cell Lung Cancer (ALBATROS) | 15 juin 2024 | |
| NCT05056714 | Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score) (PSI) | 15 juin 2024 | |
| NCT04356326 | Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a Multicenter Prospective Randomized Double-blind Placebo-controlled Trial. (CHASAP) | 15 juin 2024 | |
| NCT03981653 | Angiogenic Function at Normal Term on Placenta (ANNOTEP) | 15 juin 2024 | |
| NCT05374720 | Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy (CILTUBE) | 15 juin 2024 | |
| NCT03963986 | Impacts of Remote Digital Support on Adapted Physical Activity for Patients in Pre-bariatric Surgery Care Pathways (STIMUL) | 15 juin 2024 | |
| NCT05078047 | Randomized Phase III Trial of Standard Immunotherapy (IO) by Checkpoint Inhibitors, Versus Reduced Dose Intensity of IO in Patients With Locally Advanced or Metastatic Cancer in Response After 6 Months of Standard IO (MOIO) | 15 juin 2024 | |
| NCT06176352 | A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia (POYANG) | 15 juin 2024 | |
| NCT04424303 | Evaluation of the Clinical Benefit of ToFAcitinib Treatment in Patients With Moderate to Severe Ulcerative Colitis Under Real-life Conditions of Use: TOFAst Study (TOFAST) | 15 juin 2024 | |
| NCT03940703 | A Phase II, Two-arm Study to Investigate Tepotinib Combined With Osimertinib in MET Amplified, Advanced or Metastatic NSCLC Harboring Activating EGFR Mutations and Having Acquired Resistance to Prior Osimertinib Therapy (INSIGHT 2) | 15 juin 2024 | |
| NCT05476926 | Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY) (VOYAGER) | 15 juin 2024 | |
| NCT04616326 | A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study (REBUILD-2) | 15 juin 2024 | |
| NCT04115007 | Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients - a GETUG-AFU Phase III Randomized Controlled Trial (Oligo-PRESTO) | 15 juin 2024 | |
| NCT02784171 | A Phase II/III Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma | 15 juin 2024 | |
| NCT06356909 | Study of PREMEdication Before Laryngoscopy in Neonates in France: a National Prospective Survey in French Neonatal Units and Neonatal Transport Teams (SUPREMEneo) | 15 juin 2024 | |
| NCT06012435 | A Randomized, Phase 3, Open-label Study to Evaluate Sigvotatug Vedotin Compared With Docetaxel in Adult Participants With Previously Treated Non-small Cell Lung Cancer (Be6A Lung-01) | 15 juin 2024 | |
| NCT05092659 | Patient Experience in Bariatric Surgery: Definition of New Indicators (CALEX) | 15 juin 2024 | |
| NCT04228016 | Efficacy of an Intranasal Stent on Nasal Obstruction at Night: A Prospective Multicenter Study (RHINASTENT) | 15 juin 2024 | |
| NCT05157685 | Evaluation of the Efficacy of 3-month Continuous Extended Treatment With Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults: a Multicentre Randomised Controlled Trial (SOPAZITHRO) | 15 juin 2024 | |
| NCT04396236 | Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1 (PIONEER-PEDS1) | 10 juin 2024 | |
| NCT05714995 | Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Care of Patients Followed in Oncology for Cancer Within a Mobile Palliative Care Support Team (EMASP) (HYPNO-AROMA) | 10 juin 2024 | |
| NCT05450692 | A Phase III, Open-label, Randomised, Multicentre Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations, and Whose Disease Has Progressed On or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy: LATIFY (LATIFY) | 06 juin 2024 | |
| NCT04770545 | A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GALE) | 29 mai 2024 | |
| NCT06150703 | Luteal Phase Support With GnRH Agonist Alone After GnRH Agonist Triggering and Fresh Embryo Transfer Compared to the Reference Protocol (hCG Triggering and Progesterone Luteal Support): a Randomised Controlled Trial (SOLOAGO) | 23 mai 2024 | |
| NCT05697146 | Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France: a National, Multicenter, Prospective, Non-interventional Study (RosaLEE) | 14 mai 2024 | |
| NCT01564056 | Adjuvant Systemic Treatment for Oestrogen-receptor (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) Multicentre Phase III Trial (ASTER 70s) | 13 mai 2024 | |
| NCT04685850 | Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans in Ile de France: a Multidisciplinary Approach (SEINE) | 13 mai 2024 | |
| NCT03825874 | Comparison of the Impact on Digestive Portage of Broad Spectrum Beta-Lactamase-Producing Enterobacteriaceae (E-ESBLs) of Proposed Treatments in Outbreaks of Childhood Urinary Tract Infection (MIKA) | 13 mai 2024 | |
| NCT04700306 | Evaluation of the Added Value of Sophrology on the Intensity of Craving During Smoking Withdrawal (SOPHCIG) | 13 mai 2024 | |
| NCT03306251 | ANRS CO11 : National Cohort of Children Born to HIV-positive Mothers (EPF) | 13 mai 2024 | |
| NCT04361604 | Clinical Characterisation Protocol for COVID-19 in People Living With HIV (COVIDHIV) | 10 mai 2024 | |
| NCT03899155 | Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies | 06 mai 2024 | |
| NCT02834884 | SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access (SPECTA) | 19 avril 2024 | |
| NCT04928846 | A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer | 19 avril 2024 | |
| NCT04594369 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects With Non-Cystic Fibrosis Bronchiectasis - The ASPEN Study (ASPEN) | 16 avril 2024 | |
| NCT05227547 | Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease (CoStemCells) | 05 avril 2024 | |
| NCT04336956 | Covid-19 Pediatric Observatory (PANDOR) | 31 mars 2024 | |
| NCT05184712 | A Randomized, Double-blind, Multi-center, Phase III Study of AK112 Combined With Pemetrexed and Carboplatin Versus Placebo Combined With Pemetrexed and Carboplatin in Patients With Locally Advanced or Metastatic EGFR-mutant Non-squamous NSCLC Who Have Failed Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs) | 29 mars 2024 | |
| NCT05920356 | A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C (CodeBreaK 202) | 29 mars 2024 | |
| NCT05437198 | Study of Microbiological Diversity in Exhaled Air in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Subjects Free of COPD (EXHALBIO) | 29 mars 2024 | |
| NCT04233021 | A Phase II, Multi-centre Study, to Evaluate the Efficacy and Safety of Osimertinib Treatment for Patients with EGFR-mutated Non-small Cell Lung Cancer (NSCLC) with Brain or Leptomeningeal Metastases (ORBITAL) | 29 mars 2024 | |
| NCT04085536 | Multicenter Prospective Longitudinal Study on the Efficacy of Exclusive Odontological and Medical Treatment in the Management of Chronic Dental Maxillary Sinusitis (DENTASINUS) | 29 mars 2024 | |
| NCT05156398 | A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age | 29 mars 2024 | |
| NCT04526782 | A Phase II Study of the BRAF Inhibitor Encorafenib in Combination with the MEK Inhibitor Binimetinib in Patients with BRAFV600E-mutant Metastatic Non-small Cell Lung Cancer (ENCO-BRAF) | 29 mars 2024 | |
| NCT05403385 | A Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating Efficacy and Safety of Inupadenant in Combination with Carboplatin and Pemetrexed in Adults with Nonsquamous Non-small Cell Lung Cancer Who Have Progressed on Immunotherapy | 29 mars 2024 | |
| NCT05609578 | A Phase 2 Trial of Combination Therapies With Adagrasib in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation | 29 mars 2024 | |
| NCT06023589 | A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON) (HORIZON) | 29 mars 2024 | |
| NCT05630820 | Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B Virus (B-Well 2) (B-Well 2) | 29 mars 2024 | |
| NCT04736173 | A Phase 3 Study to Evaluate Zimberelimab (AB122) Combined With AB154 in Front-Line, PD-L1-High, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (ARC-10) | 29 mars 2024 | |
| NCT05711394 | A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic Migraine in Pediatric Subjects 6-17 Years of Age. (Kaleidoscope) | 29 mars 2024 | |
| NCT05692180 | Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA) (DOMINICA) | 29 mars 2024 | |
| NCT05521776 | Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity : a Multicenter Randomized Trial (RANSPRE) | 29 mars 2024 | |
| NCT05536297 | An Open-label Extension (OLE) Phase 3 Trial to Assess the Safety of Intravitreal Administration of Avacincaptad Pegol (Complement C5 Inhibitor) in Patients With Geographic Atrophy Who Previously Completed Phase 3 Study ISEE2008 (GATHER2) | 29 mars 2024 | |
| NCT05633771 | A Multicenter, International, Prospective, Non-interventional, Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting (HYRISS) | 29 mars 2024 | |
| NCT05544565 | 3-day Intravenous Antibiotic Treatment Versus 3-day Intravenous Followed by 7-day Oral Antibiotic Treatment for Acute Pyelonephritis in Children 1 Month to 3 Years Old: a Non-inferiority Open Randomized Multicentric Clinical Trial (PYELOCOURT) | 29 mars 2024 | |
| NCT05072782 | Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) (POMEROL) | 29 mars 2024 | |
| NCT05153239 | A Randomized, Multicenter, Open-label, Phase III Study of Lurbinectedin Single-Agent or Lurbinectedin in Combination With Irinotecan Versus Investigator's Choice (Topotecan or Irinotecan) in Relapsed Small Cell Lung Cancer Patients (LAGOON Trial) | 29 mars 2024 | |
| NCT04868877 | Phase 1/2 Dose Escalation and Expansion Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors | 29 mars 2024 | |
| NCT05300724 | A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration (HONU) | 29 mars 2024 | |
| NCT05273047 | Assessment and Follow-up of Patients With KRAS G12C-mutated Metastatic Non-Small Cell Lung Cancer Who Received Sotorasib as Part of the French Early Access Program (ATU) (LungKG12Ci) | 29 mars 2024 | |
| NCT05089734 | Open-Label, Global, Multicenter, Randomized, Phase 3 Study of Sacituzumab Govitecan Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy (EVOKE-01) | 29 mars 2024 | |
| NCT05261399 | A Phase III, Randomised, Open-Label Study of Savolitinib in Combination With Osimertinib Versus Platinum-Based Doublet Chemotherapy in Participants With EGFR Mutated, MET-Overexpressed and/or Amplified, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed on Treatment With Osimertinib (SAFFRON). (SAFFRON) | 29 mars 2024 | |
| NCT04942639 | Phase 3, Multi-centre, Prospective, Open, Randomized, in Two Parallel Groups Study to Evaluate Efficacy and Tolerance of Patient's Learning in Self-taking of Prescribed Asthma Maintenance Treatments and Provided by a Robot Named JOE. (JoeCare) | 29 mars 2024 | |
| NCT05683977 | EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer. Prospective Cohort of Extensive Stage Small Cell Lung Cancer Patients Treated With Durvalumab Associated With Platinum-etoposide Chemotherapy (ARSENAL) | 29 mars 2024 | |
| NCT05280470 | A Phase 2, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), in Subjects With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung01) (IDeate-Lung01) | 29 mars 2024 | |
| NCT05331183 | A Phase 3 Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes | 29 mars 2024 | |
| NCT04494074 | Intérêt du Traitement de la fièvre Par Refroidissement Externe Pour la Survie Des Patients ventilés en Choc Septique | 29 mars 2024 | |
| NCT05019521 | A Phase 2, Double-Masked, Placebo-Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) | 29 mars 2024 | |
| NCT05221840 | A Phase III, Double-blind, Placebo-controlled, Randomised, Multicentre, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizumab in Patients With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Definitive, Platinum-Based Concurrent Chemoradiation Therapy (PACIFIC-9) | 29 mars 2024 | |
| NCT05274750 | A Randomised, Double-blind, Parallel Group Phase III Study to Assess the Efficacy and Safety of 100 mg SC Depemokimab in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) - ANCHOR-1 (depemokimAb iN CHrOnic Rhinosinusitis) (ANCHOR-1) | 29 mars 2024 | |
| NCT03472157 | Prospective Multicentric, Open Label, Randomized Clinical Trial of Superiority, With Two Arms, Comparing Bariatric Surgery to the Recommended Medical Treatment for NASH (NASHSURG) | 29 mars 2024 | |
| NCT04915014 | Prospective Multicentric Randomized Trial Comparing the Efficacy and Safety of Sleeve Gastrectomy With Transit Bipartition (SG+TB) Versus Roux-en-Y Gastric Bypass (RYGB) (BIPASS) | 29 mars 2024 | |
| NCT04074018 | Clinical, Kinematic and Quality-of-life Related Impacts of Two Rehabilitation Programs in Chronic Peripheral Facial Paresis: a Randomized Control Trial. (VISAGE) | 29 mars 2024 | |
| NCT04554108 | Acute Non-severe Osteomyelitis in Children - Outpatient Management Strategy With Oral Antibiotic Therapy Compared to a Standard Strategy With Conventional Hospitalization and Intravenous Antibiotic Therapy: a Randomized Open-label Non-inferiority Study With Bayesian and Medical-economic Analyses. (POOMA) | 29 mars 2024 | |
| NCT04655976 | A Randomized, Open Label Phase 2/3 Study Comparing Cobolimab + Dostarlimab + Docetaxel To Dostarlimab + Docetaxel To Docetaxel Alone In Participants With Advanced Nonsmall Cell Lung Cancer Who Have Progressed On Prior Anti-PD-(L)1 Therapy And Chemotherapy (COSTAR Lung) (COSTAR Lung) | 29 mars 2024 | |
| NCT04348838 | Prospective Cohort of Patients With Hepatocellular Carcinoma in France (CHIEF) | 29 mars 2024 | |
| NCT02215265 | A Phase III Trial of Risk-stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (PATHOS) | 29 mars 2024 | |
| NCT03539536 | Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects With Previously Treated c-Met+ Non-Small Cell Lung Cancer | 29 mars 2024 | |
| NCT04550182 | Evaluation of the Impact of the Repositioning Schedule Adapted to the Risk of Pressure Ulcer of Patients in Intensive Care Unit (PROMESREA) | 29 mars 2024 | |
| NCT04127110 | Activity of Lorlatinib Based on ALK Resistance Mutations on Blood in ALK Positive NSCLC Patients Previously Treated With 2nd Generation ALK Inhibitor (ALKALINE) | 29 mars 2024 | |
| NCT04677569 | ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC) (ENCORE) | 29 mars 2024 | |
| NCT04292080 | Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy (LADIGAGA) | 29 mars 2024 | |
| NCT04676854 | Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration (PRIMAvera) | 29 mars 2024 | |
| NCT04475939 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L) (ZEAL-1L) | 29 mars 2024 | |
| NCT04396574 | A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2 (PIONEER-PEDS2) | 29 mars 2024 | |
| NCT04116398 | Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX) | 29 mars 2024 | |
| NCT03849131 | Patient-Reported AutoImmunity Secondary to Cancer immunothErapy (PRAISE) | 29 mars 2024 | |
| NCT04459117 | Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen (TREOCAPA) | 29 mars 2024 | |
| NCT04412317 | National Observatory of the Care of Young Sick Children in Community or Not, Indications and Cost-effectiveness of PCR-Sars-CoV-2 - VIGIL Study (VIGIL) | 29 mars 2024 | |
| NCT03464097 | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease | 29 mars 2024 | |
| NCT04111705 | A Phase II Non-randomized, Single Group Assignment, Open-label, Multicenter Study of Efficacy and Safety of Lorlatinib Monotherapy After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients with Advanced ALK-positive Non-small Cell Lung Cancer (ORAKLE) | 29 mars 2024 | |
| NCT03486873 | A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab | 29 mars 2024 | |
| NCT03541876 | Data Collection for the Creation of the French Pediatric Helicobacter Pylori Observatory (GFHPP) | 29 mars 2024 | |
| NCT04077528 | Research on Severe Asthma (RAMSES) | 29 mars 2024 | |
| NCT03313206 | Phase II Multicentric Study: Efficacy Evaluation of Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy on Disease-free-survival (DFS) in Patients With Resectable Head and Neck Mucosal Melanoma (IMMUQ) | 29 mars 2024 | |
| NCT03600883 | A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100) | 29 mars 2024 | |
| NCT03354936 | A Multicenter Observational Cohort for HIV Infected Patients With a Cancer Treated by Immune-Checkpoint Inhibitors. (OncoVIHAC) | 29 mars 2024 | |
| NCT02589691 | Addition of Neuromuscular-Blocking Agents During Sevoflurane Induction in Infants : Potential Interest in Reducing Hypoxemia Episodes (ROC-HYPOX) | 29 mars 2024 | |
| NCT03669523 | A Multicenter Phase II Study Evaluating Denosumab (XGEVA®) in Combination With Nivolumab (OPDIVO®) as Second-line Therapy for Patients With Stage IV Non-small-Cell Lung Cancer (Squamous and Non-squamous) With Bone Metastases: DENIVOS STUDY (DENIVOS) | 29 mars 2024 | |
| NCT03591731 | A GCO Trial Exploring the Efficacy and Safety of Nivolumab Monotherapy or Nivolumab Plus Ipilimumab in Pre-treated Patients with Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs) (NIPINEC) | 29 mars 2024 | |
| NCT03236987 | CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections (CLAZI) | 29 mars 2024 | |
| NCT03848052 | Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 | 29 mars 2024 | |
| NCT02596763 | Phone-based Safety Monitoring of the First Year of Baclofen Treatment for Alcohol Use Disorder: the BACLOPHONE Cohort Study (BACLOPHONE) | 29 mars 2024 | |
| NCT03235310 | ANRS CO1 EPF Prospective Observational Cohort Study on Mother-to-child Transmission HIV1 and/or HIV2 and Prevention (EPF) | 29 mars 2024 | |
| NCT01520844 | Multicentric Cohort of HIV Patient With Extrem Profil (CODEX) | 29 mars 2024 | |
| NCT03148964 | Multicentric Cohort of HIV-1 (Human Immunodeficiency Virus 1) Primary Infection Cohort ANRS CO6 PRIMO (PRIMO) | 29 mars 2024 | |
| NCT02998385 | A Phase III Randomized Study of Chemo-radiotherapy Versus Radiotherapy Alone in the Adjuvant Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy) (SANTAL) | 29 mars 2024 | |
| NCT03127995 | Multicenter Randomized Phase III Trial Comparing Hypofractionated Versus Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation in Terms of Lymphedema Occurrence (HYPOG-01) | 29 mars 2024 | |
| NCT03006432 | ESSAI DE PHASE III RANDOMISE EVALUANT LE FOLFOX AVEC OU SANS DOCETAXEL (TFOX) EN 1ère LIGNE DE CHIMIOTHERAPIE DES ADENOCARCINOMES OESO-GASTRIQUES LOCALEMENT AVANCES OU METASTATIQUES (GASTFOX) | 29 mars 2024 | |
| NCT03614481 | Clinical and Genetic Analyzes of Age-related Macular Degeneration (COLDMLA) | 29 mars 2024 | |
| NCT05753384 | Discontinuation of TyrosIne Kinase Inhibitors (ITK) in Chronic Myeloid Leukemia (LMC) and Impact on the Immune System: a Randomized Comparative Study of Two Therapeutic Strategies | 22 mars 2024 | |
| NCT06247826 | Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (RESAMEX) | 09 février 2024 | |
| NCT04863547 | Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection (SEVASAR) | 20 octobre 2023 | |
| NCT03852004 | Comparison of Osteopathic Treatment Versus Simulation on Motor Development of Hypotonic Infants. (HYPOSTEO) | 13 mai 2023 | |
| NCT05226364 | Effect of Tourniquet Abstention on Pain Reduction in Venous Sampling in the Elderly People : Randomized Trial (NO-GARROT) | 27 avril 2023 | |
| NCT04042701 | A Phase 1b, Multicenter, Two-Part, Open-Label Study of Trastuzumab Deruxtecan (DS-8201a), An Anti-Human Epidermal Growth Factor Receptor-2 (HER2)-Antibody Drug Conjugate (ADC), In Combination With Pembrolizumab, An Anti-PD-1 Antibody, For Subjects With Locally Advanced/Metastatic Breast Or Non-Small Cell Lung Cancer (NSCLC) | 27 avril 2023 | |
| NCT03861897 | Efficacy of Non-instrumental Pleural Chest Physiotherapy (KRP-NI) in Initial Management of Infectious Pleural Effusion (KINEPANCH) | 27 avril 2023 | |
| NCT01963442 | A Non-Inferiority, Multicentered, Controlled, Randomized, Double Blinded Study Investigating the Antibiotic Treatment Duration (3-day Versus 8-day) for Subjects Admitted to Emergency Services With Acute Non-severe Community Acquired Pneumonia (CAP) (PTC) | 20 mars 2023 | |
| NCT00908401 | Breastmilk or Oral Sucrose Solution in Preterm Neonates for Procedural Pain: a Randomized, Controlled Study (BMoS) | 20 mars 2023 | |
| NCT03971136 | Evaluation of the Interest of Pulmonary Ultrasound in the Diagnosis and Early Detection of Acute Thoracic Syndrome in Hospitalized Children for Vaso-occlusive Sickle Cell Crisis: Multicenter Prospective Study (ECHO-STA) | 20 mars 2023 | |
| NCT03963622 | Careful Ventilation in Acute Respiratory Distress Syndrome (CAVIARDS) | 08 novembre 2022 |